[Tumor microenvironment and the pathologist: looking at what we just see]

Area of Science:

• Oncology
• Molecular Biology
• Immunology

Context:

• Molecular technology advances have significantly improved tumor biology knowledge.
• The tumor microenvironment, previously termed 'stroma reaction', is increasingly recognized for its importance in cancer management.
• Pathologists have historically used tumor microenvironment features for diagnosing histological subtypes.

Purpose:

• To highlight the critical role of the tumor microenvironment in cancer prognosis.
• To explore the potential of tumor microenvironment research in developing new cancer treatments.
• To emphasize the need for rigorous validation of prognostic and predictive biomarkers derived from tumor microenvironment research.

Summary:

• Research increasingly shows the tumor microenvironment, particularly the immune response, plays a key role in cancer prognosis.
• Analysis of the tumor microenvironment offers new therapeutic strategies for cancer patients.
• Biomarkers from tumor microenvironment research must undergo validation before clinical implementation.

Impact:

• Improved understanding of cancer biology beyond the cancer cell itself.
• Potential for more accurate cancer prognosis and personalized treatment strategies.
• Development of novel diagnostic and therapeutic biomarkers for improved patient outcomes.